DOI QR코드

DOI QR Code

Expression of Pseudorabies Virus Glycoproteins gB, gC and gD using Insect Expression System

  • Yun, Bit Na Rae (Department of Agricultural Biology, College of Agriculture, Life & Environment Science, Chungbuk National University) ;
  • Gwak, Won Seok (Department of Agricultural Biology, College of Agriculture, Life & Environment Science, Chungbuk National University) ;
  • Lee, Ji Hoon (Department of Agricultural Biology, College of Agriculture, Life & Environment Science, Chungbuk National University) ;
  • Woo, Soo Dong (Department of Agricultural Biology, College of Agriculture, Life & Environment Science, Chungbuk National University)
  • Received : 2017.11.10
  • Accepted : 2017.12.12
  • Published : 2017.12.31

Abstract

Porcine pseudorabies virus (PRV) causes the Aujeszky's disease (AD) which is economically important disease in the swine industry worldwide. Killed or live vaccines have been used to control this disease, but their efficacy and side effects remain problems to be solved. To solve these problems, in this study, production of recombinant PRV glycoprotein gB, gC and gD was investigated in insect expression system. Glycoprotein gB, gC and gD are regarded as the major immunogenic antigens in PRV. Abundant production and immunogenicity of glycoprotein gB, gC and gD were confirmed by SDS-PAGE and Western blot analysis, respectively. Optimal infection dose and time were also determined for the production of each recombinant PRV glycoprotein. Confirmation of glycosylation of recombinant gB, gC and gD suggested their usefulness as antigens for the development of diagnosis kit or vaccines for Aujeszky's disease.

Keywords

References

  1. Beljelarskaya SN (2002) A baculovirus expression system for insect cells. Mol Biol 36, 281-292. https://doi.org/10.1023/A:1016021306893
  2. Grabowska AK, Lipinska AD, Rohde J, Szewczyk B, Bienkowska-Szewczyk K, Rziha HJ (2009) New baculovirus recombinants expressing Pseudorabies virus (PRV) glycoproteins protect mice against lethal challenge infection. Vaccine 27, 3584-3591. https://doi.org/10.1016/j.vaccine.2009.03.067
  3. Gromadzka B, Szewczyk B, Konopa G, Mitzner A, Kesy A (2006) Recombinant VP60 in the form of virion-like particles as a potential vaccine against rabbit hemorrhagic disease virus. Acta Biochim Pol 53, 371-376.
  4. Hink WF, Thomsen DR, Davidson DJ, Meyer AL, Castellino FJ (1991) Expression of three recombinant proteins using baculovirus vectors in 23 insect cell lines. Biotechnol Prog 7, 9-14. https://doi.org/10.1021/bp00007a002
  5. Hong W, Xiao S, Zhou R, Fang L, He Q, Wu B, Zhou F, Chen H (2002) Protection induced by intramuscular immunization with DNA vaccines of pseudorabies in mice, rabbits and piglets. Vaccine 20, 1205-1214. https://doi.org/10.1016/S0264-410X(01)00416-9
  6. Je YH, Chang JH, Kim MH, Roh JY, Jin BR, O'Reilly DR (2001) The use of defective Bombyx mori nucleopolyhedrovirus genomes maintained in Escherichia coli for the rapid generation of occlusion-postitive and occlusion-negative expression vectors. Biotechnol Lett 23, 1809-1817. https://doi.org/10.1023/A:1012475004212
  7. Katzen F, Peterson TC, Kudlicki W (2009) Membrane protein expression: no cells required. Trends Biotechnol 27, 455-460. https://doi.org/10.1016/j.tibtech.2009.05.005
  8. Kluge JP, Beran GW, Hill HT, Platt KB (1999) Diseases of swine. Pseudorabies (Aujeszky's Disease), 8th ed. Iowa State University Press (Ames, Iowa), pp. 233-246.
  9. Koo HN, Bae SM, Choi JB, Shin TY, Yun BNR, Choi JY, Lee KS, Roh JY, Je YH, Jin BR, Yoo SS, Kim JS, Kim YI, Yoon IJ, Woo SD (2011) Characterization and expression of the pseudorabies virus (NYJ strain) glycoproteins in Bombyx mori cells and larvae. J Asia-Pacific Entomol 14, 107-117. https://doi.org/10.1016/j.aspen.2010.08.002
  10. Lee JB, Bae SM, Shin TY, Woo SD (2015) Expression of porcine circovirus type 2 capsid protein fused with partial polyhedrin using baculovirus. Int J Indust Entomol 30, 50-57. https://doi.org/10.7852/ijie.2015.30.2.50
  11. Matassov P, Cupo A, Galarza JM (2007) A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1). Viral Immunol 20, 441-452. https://doi.org/10.1089/vim.2007.0027
  12. Mettenleiter TC (1994) Pseudorabies (Aujeszky's disease) virus: state of the art. Acta Vet Hung 42, 153-177.
  13. Mettenleiter TC (1996) Immunobiology of pseudorabies (Aujeszky's disease). Vet Immunol Immunopathol 54, 221-229. https://doi.org/10.1016/S0165-2427(96)05695-4
  14. Mettenleiter TC (2000) Aujeszky's disease (pseudorabies) virus: the virus and molecular pathogenesis-state of the art. Vet Rec 31, 99-115.
  15. Mukamoto M, Watanabe I, Kobayashi Y, Icatlo Jr. FC, Ishii H, Kodama Y (1991) Immunogenicity in Aujeszky's disease virus structural glycoprotein gVI (gp50) in swine. Vet Microbiol 29, 109-121. https://doi.org/10.1016/0378-1135(91)90119-Z
  16. Mulder WA, Pol JM, Gruys E, Jacobs L, De Jong MC, Peeters BP, Kimman TG (1997) Pseudorabies virus infections in pigs. Role of viral proteins in virulence, pathogenesis and transmission. Vet Res 28, 1-17.
  17. O'Reilly DR, Miller LK, Luckow VA (1992) Baculovirus Expression Vectors - A Laboratory Manual. (New York: W. H. Freeman and Company).
  18. Park SW, Goo TW, Kim SR, Choi KH (2016) Recombinant human BMP-2/-7 heterodimer protein expression for bone tissue engineering using recombinant baculovirus expression system. Int J Indust Entomol 32, 49-53. https://doi.org/10.7852/ijie.2016.32.2.49
  19. Prud'homme I, Zhou EM, Traykova M, Trotter H, Chan M, Afshar A, Harding MJ (1997) Production of a baculovirus-derived gp50 protein and utilization in a competitive enzyme-linked immunosorbent assay for the serodiagnosis of pseudorabies virus. Can J Vet Res 61, 286-291.
  20. Shams H (2005) Recent developments in veterinary vaccinology. Vet J 170, 289-299. https://doi.org/10.1016/j.tvjl.2004.07.004
  21. van Rooij EM, Haagmans BL, Glansbeek HL, de Visser YE, de Bruin MG, Boersma W, Bianchi AT (2000) A DNA vaccine coding for glycoprotein B of pseudorabies virus induces cell-mediated immunity in pigs and reduces virus excretion early after infection. Vet Immunol Immunopathol 74, 121-136. https://doi.org/10.1016/S0165-2427(00)00170-7
  22. Yoon HA, Aleyas AG, George JA, Park SO, Han YW, Kang SH, Cho JG, Eo SK (2006) Differential segregation of protective immunity by encoded antigen in DNA vaccine against pseudorabies virus. Immunol Cell Biol 84, 502-511. https://doi.org/10.1111/j.1440-1711.2006.01463.x
  23. Yun BNR, Bae SM, Lee JB, Kim HJ, Woo SD (2011) Expression of pseudorabies virus (PRV) glycoproteins gB, gC and gD using bacterial expression system. Int J Indust Entomol 23, 147-153. https://doi.org/10.7852/ijie.2011.23.1.147